Cloning of a New Gene/s in Chromosome 17p3.2-p13.1 that Control Apoptosis
Abstract
Loss of genetic material (LOH) in the chromosome 17 p13 .2 at the microsatellite marker Dl7S796 has been identified in atypical ductal hyperplasia and in situ ductal carcinoma of the breast. Our results shown LOH at the same region in MCF-lOF cells treated with the chemical carcinogen benz(a)pyrene (BP). Moreover, microcell-mediated transfer of an intact copy of human chromosome 17 inhibited the tumorigenicity of BPlE and PCR-SSCP analyzes showed a restoration of the lost material in BPlE-17-neo. These experiments suggested the presence of a tumor suppressor gene in 17pl3 .2 near the marker Dl 7S796. We have been able to clone a fragment of the genes that could represent the last exon of a bigger peptide. The presence of a 3' splicing site in the putative introns and the ATTAAA region at the 3'end support this idea. The predicted amino acid sequence does not share significant homology with any known protein supporting the idea that this could be a novel protein. Further experiments will be done in order to clone the full-Length cDNA and to study the regulation of the expression of this novel gene.
Document Details
- Document Type
- Technical Report
- Publication Date
- Apr 01, 2004
- Accession Number
- ADA425683
Entities
People
- Jose Russo
Organizations
- Fox Chase Cancer Center